Kamada Ltd.
General ticker "KMDA" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $384.1M (TTM average)
Kamada Ltd. follows the US Stock Market performance with the rate: 48.3%.
Estimated limits based on current volatility of 2.0%: low 8.77$, high 9.13$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-03-17, amount 0.20$ (Y2.21%)
- Total employees count: 289 as of 2013
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.25$, 8.06$]
- 2025-12-31 to 2026-12-31 estimated range: [5.60$, 8.59$]
Financial Metrics affecting the KMDA estimates:
- Positive: with PPE of 22.9 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 13.93 > 12.96
- Positive: 7.67 < Operating profit margin, % of 12.46
- Negative: negative Industry operating cash flow (median)
- Positive: -4.43 < Investing cash flow per share per price, % of -3.14
- Positive: Inventory ratio change, % of -5.39 <= -0.75
- Negative: negative Industry operating income (median)
- Positive: Interest expense per share per price, % of 0.19 <= 0.73
Short-term KMDA quotes
Long-term KMDA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $129.34MM | $142.52MM | $160.95MM |
| Operating Expenses | $124.81MM | $132.46MM | $140.90MM |
| Operating Income | $4.53MM | $10.06MM | $20.05MM |
| Non-Operating Income | $-6.79MM | $-1.64MM | $-6.72MM |
| Interest Expense | $0.91MM | $1.30MM | $0.66MM |
| R&D Expense | $13.17MM | $13.93MM | $15.19MM |
| Income(Loss) | $-2.26MM | $8.43MM | $13.33MM |
| Taxes | $0.06MM | $0.14MM | $-1.13MM |
| Profit(Loss)* | $-2.32MM | $8.28MM | $14.46MM |
| Stockholders Equity | $176.02MM | $244.02MM | $259.46MM |
| Inventory | $72.52MM | $88.48MM | $78.82MM |
| Assets | $322.38MM | $354.91MM | $372.25MM |
| Operating Cash Flow | $28.59MM | $4.32MM | $47.59MM |
| Capital expenditure | $3.78MM | $5.85MM | $10.74MM |
| Investing Cash Flow | $-3.78MM | $-5.84MM | $-10.74MM |
| Financing Cash Flow | $-9.34MM | $22.68MM | $-13.91MM |
| Earnings Per Share** | $-0.05 | $0.17 | $0.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.